Sources behind the guides
Primary references checked October 10, 2026. Guidance and labeling can change.
Medical claims link to the relevant source near the discussion. Local sources support geography, not treatment availability. Source inclusion does not imply an endorsement of this website.
- FDA: potential safety risks for certain compounded substances ↗
Identifies specific substances and FDA safety concerns; entries and routes must be read individually.
- FDA: concerns with unapproved GLP-1 drugs ↗
Explains FDA concerns about unapproved and compounded GLP-1 products.
- FDA: compounding questions and answers ↗
Explains the role and regulatory limitations of compounded drugs.
- Florida Department of Health: license and enforcement search ↗
Official search for licensing and enforcement information.
- Florida Department of Health: verify a healthcare professional ↗
Official professional-license verification. Licensure alone is not a treatment endorsement.
- Florida Department of Health: verify a pharmacy license ↗
Primary reference used in the guides. Follow the link for the current source text.
- Florida Department of Health: telehealth FAQs ↗
Florida guidance on licensure, registration, and care across state borders.
- FDA: is it really FDA approved? ↗
Primary reference used in the guides. Follow the link for the current source text.
- FDA: Zepbound approval announcement ↗
Historical Zepbound approval announcement. Consult current labeling for current indications.
- Operation Supplement Safety: BPC-157 ↗
Primary reference used in the guides. Follow the link for the current source text.
- City of Sarasota: neighborhoods ↗
Official city neighborhood context; no treatment availability is implied.
- Sarasota County: municipalities ↗
Primary reference used in the guides. Follow the link for the current source text.
Interpretation and checklists on this website are educational editorial guidance. For a decision about your care, discuss the original source with your clinician.